Alzheimer’s Drug Discovery Foundation’s Diagnostics Accelerator (DxA) invests $10M in Alamar Biosciences, Inc. to Advance Precision Medicine in Alzheimer’s Disease
Largest DxA investment to date supports development of Alamar’s ARGO™ DX System and future in vitro diagnostic tests